AMAGX
Price
$68.63
Change
-$2.48 (-3.49%)
Updated
Apr 10 closing price
Net Assets
4.81B
GFACX
Price
$56.51
Change
-$2.32 (-3.94%)
Updated
Apr 10 closing price
Net Assets
271.59B
Ad is loading...

AMAGX vs GFACX

Header iconAMAGX vs GFACX Comparison
Open Charts AMAGX vs GFACXBanner chart's image
Amana Growth Investor
Price$68.63
Change-$2.48 (-3.49%)
VolumeN/A
Net Assets4.81B
American Funds Growth Fund of Amer C
Price$56.51
Change-$2.32 (-3.94%)
VolumeN/A
Net Assets271.59B
AMAGX vs GFACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AMAGX vs. GFACX commentary
Apr 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMAGX is a Hold and GFACX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 272B vs. AMAGX (4.81B). AMAGX (0.00) and GFACX (0.00) have matching dividends . AMAGX was incepted earlier than GFACX: AMAGX (31 years) vs GFACX (24 years). GFACX (1.36) is less costly to investors than AMAGX (0.87). GFACX is a more actively managed with annual turnover of: 25.00 vs. AMAGX (10.00). AMAGX has a lower initial minimum investment than GFACX: AMAGX (100) vs GFACX (250). GFACX annual gain was more profitable for investors over the last year : -3.95 vs. AMAGX (-8.21). AMAGX return over 5 years is better than : 75.81 vs. GFACX (40.74).
AMAGXGFACXAMAGX / GFACX
Total Expense Ratio0.871.3664%
Annual Report Gross Expense Ratio0.871.3664%
Fund Existence31 years24 years-
Gain YTD-10.587-7.732137%
Front LoadN/AN/A-
Min. Initial Investment10025040%
Min. Initial Investment IRAN/AN/A-
Net Assets4.81B272B2%
Annual Yield % from dividends0.000.00-
Returns for 1 year-8.21-3.95208%
Returns for 3 years11.434.35263%
Returns for 5 years75.8140.74186%
Returns for 10 years109.1738.82281%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DGLY0.03N/A
+15.27%
Digital Ally
BDSX0.570.02
+4.51%
Biodesix
TAP59.951.44
+2.46%
Molson Coors Beverage Company
GYRE7.29-0.51
-6.54%
Gyre Therapeutics
GDRX4.32-0.37
-7.89%
GoodRx Holdings